Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across Europe.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 217, doi. 10.1007/s40259-022-00523-z
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2022 AND VI 36 AND IP 2
Results: 9
1
2
Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 197, doi. 10.1007/s40259-022-00522-0
- By:
- Publication type:
- Article
3
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 153, doi. 10.1007/s40259-022-00521-1
- By:
- Publication type:
- Article
4
A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 121, doi. 10.1007/s40259-022-00520-2
- By:
- Publication type:
- Article
5
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 105, doi. 10.1007/s40259-022-00519-9
- By:
- Publication type:
- Article
6
Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 181, doi. 10.1007/s40259-022-00518-w
- By:
- Publication type:
- Article
7
Enhancing the Response Rate to Recombinant Uricases in Patients with Gout.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 95, doi. 10.1007/s40259-022-00517-x
- By:
- Publication type:
- Article
8
Effect Modification by Indication to the Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment: A Population-Based Retrospective Cohort Study.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 205, doi. 10.1007/s40259-022-00516-y
- By:
- Publication type:
- Article
9
First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data.
- Published in:
- BioDrugs, 2022, v. 36, n. 2, p. 137, doi. 10.1007/s40259-022-00515-z
- By:
- Publication type:
- Article